# Novo Nordisk's $1.1 Billion Sickle Cell Bet Cleared Its Phase 3 Test. The Hard Part Is Still Coming.

- slug: novo-nordisks-11-billion-sickle-cell-bet-cleared-its-phase-3-test-the-hard-part-is-still-coming
- date: 2026-04-20
- category: Biotech & Life Sciences

Novo Nordisk cleared a Phase 3 test for its sickle cell pill. Whether that matters commercially depends on what happens next in a market defined by $2 million gene therapies.

---